Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  

Journal InfoeISSN: 2251-7308 
pISSN: 2228-5881 
Freq.: Quarterly
Quick linkEditorial Board 
Aims and Scope
Online Submission
IssuesAll issues (TOC)
Current Issue
Articles in Press

Permission


Powered by







Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary international open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences (the 2nd largest university in Iran). 
Publication Advantages in Advanced Pharmaceutical Bulletin are: 
  • Free of charge publication for all types of articles
  • Fast and constructive peer review
  • Easy and quick online submission of manuscripts
  • Author friendly review 
  • Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
  • Free publication of color images 
  • Worldwide visibility of papers (Open Access Journal)
  • Annual Award

Editorial Workflow

Every manuscript submitted to the journal undergoes the following workflow during the course of the peer-review process.

The entire editorial workflow is performed using the online Manuscript Tracking System. Once a manuscript is submitted for publication, the manuscript is checked by the journal's editorial office to ensure that it is suitable to go through the normal peer review process. Once this is done, the manuscript is sent to a number of Editorial Board Members based on the subject of the manuscript, the availability of the Editors, and the lack of any potential conflicts of interest with the submitting authors. The manuscript may also be sent to a number of external peer reviewers to participate in the peer review process. The journal's editors will have around two weeks to provide either a recommendation for the publication of the manuscript, along with a written commentary detailing any changes that the authors can make to improve their manuscript before final publication, or a written critique of why the manuscript should not be published.

If the majority of the editorial evaluations that are received by the end of this first round of review recommend the manuscript be rejected, the manuscript will be rejected. If all the editorial evaluations that are received recommend that the manuscript be accepted for publication, the manuscript will be accepted. Otherwise, all the received editorial evaluations will be anonymously communicated to all of the Editors who participated in the first round of the review process. Each Editor will be given an additional week to review the feedback of the other Editors and to either confirm or revise their earlier editorial recommendations. If the majority of the editorial evaluations that are received by the end of this second round of review recommend the manuscript be rejected, the manuscript will be rejected. Otherwise, the manuscript will be accepted for publication.

The editorial model is designed to provide fast peer review for each manuscript while at the same time ensuring that only manuscripts that are both rigorous and provide a useful contribution to their field of research are accepted for publication.

Since the Editors have direct review responsibilities in this editorial workflow, the identities of the Editors participating in the peer review of a particular manuscript are not revealed during the course of the peer review process. If the manuscript is rejected, the identities of the Editors will remain confidential. If the manuscript is accepted for publication, the names of the Editors who recommended the publication of the manuscript might  be published alongside the manuscript.

Each issue will be running issue and all officially accepted manuscripts will be immediately published online. State-of-the-art running issue concept gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts to be published. 


 Indexing Info:

 

 


A: 381 cites to articles published in 2014-2015 (during 2016)
B: 183 articles published in 2014-2015
A/B(2016)=2.08


 

   

 Chemical Abstracts Service

Chemical Abstracts 

  
 

 

 

 

 

 SCImago Journal & Country Rank

   

 

 

 

 

 

 


Press Manuscript Online. Powered by MAADRAYAN